Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.

BACKGROUND/AIMS Interleukin-12 (IL-12) governs the Th1-type immune response, affecting the spontaneous and treatment-induced recovery from HCV-infection. We investigated whether the IL12B polymorphisms within the promoter region (4 bp insertion/deletion) and the 3'-UTR (1188-A/C), which have been reported to influence IL-12 synthesis, are associated with the outcome of HCV infection. METHODS We analyzed 186 individuals with spontaneous HCV clearance, 501 chronically HCV infected patients, and 217 healthy controls. IL12B 3'-UTR and promoter genotyping was performed by Taqman-based assays with allele-specific oligonucleotide probes and PCR-based allele-specific DNA-amplification, respectively. RESULTS The proportion of IL12B promoter and 3'-UTR genotypes did not differ significantly between the different cohorts. However, HCV genotype 1-infected patients with high baseline viremia carrying the IL12B 3'-UTR 1188-C-allele showed significantly higher sustained virologic response (SVR) rates (25.3% vs. 46% vs. 54.5% for A/A, A/C and C/C) due to reduced relapse rates (24.2% vs. 12% vs. zero % for A/A, A/C and C/C). CONCLUSIONS IL12B 3'-UTR 1188-C-allele carriers appear to be capable of responding more efficiently to antiviral combination therapy as a consequence of a reduced relapse rate. No association of IL12B polymorphisms and self-limited HCV infection could be demonstrated.

[1]  G. Pape,et al.  The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C , 1996, Journal of Molecular Medicine.

[2]  A. Pain,et al.  A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production , 2002, Genes and Immunity.

[3]  G. Morahan,et al.  Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele , 2001, Nature Genetics.

[4]  B. Walker,et al.  Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection , 2002, Journal of Virology.

[5]  L. Cardon,et al.  Population stratification and spurious allelic association , 2003, The Lancet.

[6]  T. Santantonio,et al.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.

[7]  M. Manns,et al.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C , 2000, Nature Medicine.

[8]  D. Middleton,et al.  Genetic polymorphism of IL-12 p40 gene in immune-mediated disease , 2000, Genes and Immunity.

[9]  D. Brenner,et al.  Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal , 2003, Hepatology.

[10]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[11]  Koichiro Nakamura,et al.  Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. , 2002, Journal of dermatological science.

[12]  G. Morahan,et al.  Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit , 2000, Genes and Immunity.

[13]  G. Morahan,et al.  Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children , 2002, The Lancet.

[14]  C. Trautwein,et al.  Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B , 2002, Hepatology.

[15]  J A Quiroga,et al.  Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage. , 1998, The Journal of infectious diseases.

[16]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[17]  R. Williams,et al.  Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia , 1999, Gut.

[18]  T. Fučíková,et al.  Production of interleukins 10 and 12 by activated peripheral blood monocytes/macrophages in patients suffering from chronic hepatitis C virus infection with respect to the response to interferon and ribavirin treatment. , 2002, Immunology letters.

[19]  F. Berr,et al.  Low frequency of cirrhosis in a hepatitis C (genotype 1b) single‐source outbreak in germany: A 20‐year multicenter study , 2000, Hepatology.

[20]  K. Schulz,et al.  Bias and causal associations in observational research , 2002, The Lancet.

[21]  K. Livak,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.

[22]  T Foitzi,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .

[23]  G. Bouma,et al.  A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion , 2002, Genes and Immunity.

[24]  N. Naoumov.  Hepatitis C virus-specific CD4(+) T cells: do they help or damage? , 1999, Gastroenterology.

[25]  John A. Todd,et al.  Parameters for reliable results in genetic association studies in common disease , 2002, Nature Genetics.

[26]  D. Brenner,et al.  Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. , 2004, Gastroenterology.